Vimarsana
Biggest News Aggregation in the World

Page 3 - Micro Interventional Devices News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Micro Interventional Devices. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Micro Interventional Devices Today - Breaking & Trending Today

FDA Grants Micro Interventional Devices, Inc. Breakthrough Device Designation for the MIA-T Percutaneous Tricuspid Annuloplasty System - Vimarsana News

FDA Grants Micro Interventional Devices, Inc. Breakthrough Device Designation for the MIA-T Percutaneous Tricuspid Annuloplasty System

NEWTOWN, Pa., May 27, 2021 /PRNewswire/ -- Micro Interventional Devices (MID) has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its MIA-T Percutaneous

FDA Grants Micro Interventional Devices, Inc. Breakthrough Device Designation for the MIA™-T Percutaneous Tricuspid Annuloplasty System - Vimarsana News

FDA Grants Micro Interventional Devices, Inc. Breakthrough Device Designation for the MIA™-T Percutaneous Tricuspid Annuloplasty System

/PRNewswire/ -- Micro Interventional Devices (MID) has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its MIA™-T...

Prosthetic Heart Valve Market to Witness Growth Acceleration During 2026 - Vimarsana News

Prosthetic Heart Valve Market to Witness Growth Acceleration During 2026

Prosthetic Heart Valve Market to Witness Growth Acceleration During 2026 Prosthetic Heart Valve Market to Witness Growth Acceleration During 2026 BriefingWire.com, 5/06/2021 - Market Scenario Global Prosthetic Heart Valve market is expected to reach USD 8,392 Bn by 2026 at a CAGR of 9.5 % during the forecast period. The Global Prosthetic Heart Valve market is segmented based on type, end user region. By Product type - transcatheter valve, tissue heart valves, mechanical valve. By End User – Hospitals, Ambulatory Surgical Centers. By regi...

Micro Interventional Devices, Inc.™ Announces Submission of CE Mark Technical Documentation for the MIA-T™ Percutaneous Tricuspid Annuloplasty System - Vimarsana News

Micro Interventional Devices, Inc.™ Announces Submission of CE Mark Technical Documentation for the MIA-T™ Percutaneous Tricuspid Annuloplasty System

Share this article NEWTOWN, Pa., Jan. 28, 2021 /PRNewswire/ -- Micro Interventional Devices, Inc.™ (MID) announced today that it has submitted the required technical documentation for CE Mark approval for its MIA-T™ Percutaneous Tricuspid Annuloplasty System for tricuspid valve repair to its Notified Body. The receipt of a CE Mark would allow MID to commercialize MIA-T in the European Union in countries governed by the European Medical Device Regulations (MDR).  MID is anticipating an approval in 2021.  This will enable a treatment option for millions of patients currently at too high...

Global Valvular Heart Disease Treatment Market: Development, Current Analysis and Estimated Forecast - Vimarsana News

Global Valvular Heart Disease Treatment Market: Development, Current Analysis and Estimated Forecast

Fior Markets which is the fastest growing market research company. The report provides a comprehensive scope of the market which includes future supply and demand scenarios, changing market trends, high growth opportunities, and in-depth analysis of the future market prospects. The report features real-time developments in the global Valvular Heart Disease Treatment market encompasses a highly structured and comprehensive outlook of the market. It shows market types and applications that are categorized as ideal market segments. The report covers the competitive data analysis of the emergi...